INTRODUCTION
Biosynthesis of peptidoglycan can be divided into three stages: (i) cytoplasmic synthesis of the lipid II precursor, (ii) transport of lipid II across the cytoplasmic membrane and (iii) extracellular polymerization and cross-linking of the lipid II precursor into a mesh-like structure (Barreteau et al., 2008; Sauvage et al., 2008; Vollmer et al., 2008) . The last-named process involves the so-called penicillin-binding proteins (PBPs). The PBPs produced by Streptococcus pneumoniae fall into three classes: the bifunctional class A PBPs (PBP1a, PBP2a and PBP1b) that possess transglycosylase as well as transpeptidase activities, the monofunctional class B PBPs (PBP2x and PBP2b) which function as transpeptidases, and the low-molecular-mass carboxypeptidase DacA (Massidda et al., 2013; Sauvage et al., 2008; Zapun et al., 2008) . In contrast to the three class A PBPs, which can be individually deleted, both class B PBPs of S. pneumoniae are essential (Kell et al., 1993; Paik et al., 1999) . This implies that PBP2x and PBP2b serve, at least in part, different functions. Available evidence suggests strongly that PBP2x is indispensable for the synthesis of the septal crosswall, while PBP2b is dedicated to peripheral peptidoglycan synthesis Morlot et al., 2003; Peters et al., 2014; Zapun et al., 2008) . PBP2x consists of an N-terminal cytoplasmic tail of about 27 aa, a single membrane-spanning segment and three extracellular domains. A non-catalytic domain of unknown function, which has been suggested to be involved in protein-protein interactions or to serve as a pedestal, lies next to the transmembrane anchor (Macheboeuf et al., 2006 ). This domain is followed by the transpeptidase domain and two PASTA domains at the C-terminal end. PASTA domains are believed to function as sensors of non-cross-linked peptidoglycan (Maestro et al., 2011; Maurer et al., 2012; Paracuellos et al., 2010; Yeats et al., 2002) . Similarly, the N-terminal part of PBP2b contains a short cytoplasmic tail (~12 aa long) and a single transmembrane anchor. The extracellular portion of PBP2b is composed of two domains, an N-terminal pedestal and a C-terminal transpeptidase domain (Sauvage et al., 2008) .
As mentioned above, PBP2x and PBP2b function as transpeptidases that cross-link glycan strands during biosynthesis of pneumococcal peptidoglycan. Both enzymes have the same topology. Their large 'periplasmic' domains are anchored to the cytoplasmic membrane by a single transmembrane segment, and only very small N-terminal domains protrude into the cytoplasm. Given that PBP2x and PBP2b have the same topology and enzyme activities but different biological roles, swapping of their transmembrane anchors and cytoplasmic tails might be a useful method for gaining new insights into the specific functions of these domains. In the present study we used this approach to provide evidence that the transmembrane and cytoplasmic regions of PBP2x and PBP2b are not merely anchoring devices. Our results indicate strongly that these regions are also involved in essential intermolecular interactions with components of the septal and peripheral peptidoglycan synthesis machineries.
METHODS
Construction of S. pneumoniae mutant strains. Lists of all streptococcal strains and primers used in this study are given in Tables 1 and 2 , respectively. All transformations, cultivations and experiments performed with S. pneumoniae were carried out at 37 uC in C medium (Lacks & Hotchkiss, 1960) . DNA was introduced into pneumococcal recipient strains by natural genetic transformation, using 250 ng ml 21 synthetic CSP-1 (NH2-EMRLSKFFRDFILQRKK-COOH) to induce the competent state. CSP-1 and DNA were added to pneumococcal cultures when they reached an OD 550 of~0.05. After incubation at 37 uC for 120 min, cells were spread on Todd-Hewitt (TH) agar plates supplemented with kanamycin (400 mg ml 21 ), streptomycin (200 mg ml 21 ) or spectinomycin (200 mg ml 21 ) to select for transformants. When required, the inducer peptide ComS* (NH 2 -LPYFAGCL-COOH) was added to the medium during transformation and selection on agar plates to induce ectopic gene expression from the P comX promoter (Berg et al., 2011 .
To identify essential residues in the N-terminal cytoplasmic tail and transmembrane domain of PBP2x, point mutations were introduced into the pbp2x gene (spr0304). Genomic DNA from strain SPH165, which has wild-type pbp2x under control of the P comX promoter and the native pbp2x gene removed, was used as template. The point mutations were introduced via primers containing the desired base substitutions ( Table 2 ). The resulting PCR fragments were used to transform strain SPH154, which in addition to an intact native pbp2x gene has a Janus cassette inserted behind the P comX promoter. The same protocol was used to construct all point-mutated versions of pbp2x (strains SPH200-225, SPH240 and SPH257). As an example, the K13A mutation was introduced into PBP2x as follows. First, a PCR fragment was amplified that extended from primer khb31, located~1000 bp upstream the P comX promoter, to the primer containing the desired point mutation (khb256). Then, an overlapping fragment extending from the location of the point mutation tõ 1000 bp downstream of pbp2x was amplified with primers khb259 and khb34. The two fragments were subsequently fused by overlap extension PCR using primers khb31 and khb34. The resulting mutated fragment was used to transform strain SPH154. Bacteria in which the mutated fragment replaces the Janus cassette by double-crossover homologous recombination become resistant to streptomycin (Sung et al., 2001) . The transformation mix was therefore spread on agar plates containing streptomycin (200 mg ml
21
) to select for transformants. In the given example, the resulting mutant strain was called SPH200. To determine whether strains (SPH200-225, SPH240 and SPH257) ectopically expressing the various point-mutated versions of PBP2x are viable, attempts were made to replace the native pbp2x gene by insertion of a Janus cassette. Construction of the fragment used for this purpose is described by Berg et al. (2013) . Transformation with this fragment, which consists of the Janus cassette plus flanking sequences, was done in the presence of 0.2 mM ComS* to drive ectopic expression of the mutated pbp2x gene. Transformants were selected for by plating on TH agar containing kanamycin (400 mg ml
).
To make the PBP2x hybrid protein containing the cytoplasmic tail and transmembrane domain from PBP2b (strain SPH226), the region corresponding to codons 1-57 of pbp2b was amplified from strain RH1 with primers khb221 and khb222. Next, a PCR fragment extending from codon 69 through the C terminus of pbp2x was amplified with template DNA from strain RH1 using the primer pair khb223/khb103. The two fragments were fused by overlap extension PCR using primers khb221 and khb103. To provide flanking regions for homologous recombination, the resulting fragment was fused tõ 1000 bp upstream and downstream regions. Using DNA from strain SPH131 as a template, the upstream and downstream fragments were amplified with primers khb31/khb36 and khb33/khb34, respectively. The final PCR product was used to transform strain SPH154, giving rise to strain SPH226 (Fig. 1) .
To construct the PBP2b hybrid protein containing the cytoplasmic and transmembrane domains of PBP2x (strain SPH 227), a fragment Role of membrane-anchoring domains of PBP2x and PBP2b consisting of codons 1-68 from pbp2x was amplified from strain RH1 with primers khb102 and khb196. Then, a second fragment extending from codon 58 throughout pbp2b was amplified using the primer pair khb197/khb128. The two fragments were fused by overlap extension PCR using primers khb102 and khb128. The resulting fragment was fused to upstream and downstream flanking regions as described above. As a final step, this fragment was used to transform strain SPH154, giving rise to strain SPH227 ( Fig. 1) .
A PBP2x hybrid protein containing the cytoplasmic tail from PBP2b (strain SPH228) was made by amplifying a fragment encompassing codons 1-13 from pbp2b. The fragment was amplified with template DNA from strain RH1 and primers khb221 and khb224. A second fragment encompassing the region from codon 29 throughout pbp2x was amplified from RH1 with primers khb225 and khb103. Then, the primer pair khb221/khb103 was used to fuse the two fragments by overlap extension PCR. Finally, upstream and downstream flanking regions were fused to the hybrid gene construct as described above. The resulting DNA fragment was used to transform strain SPH154, giving rise to strain SPH228.
To construct the PBP2b fusion protein containing the cytoplasmic tail of PBP2x (strain SPH229), a fragment corresponding to codons 1-28 from pbp2x was amplified from strain RH1 with primers khb102 and khb227. This fragment was fused to a second fragment extending from codon 13 throughout pbp2b. The second fragment was amplified from RH1 DNA with primers khb226 and khb128. Overlap extension PCR was used to fuse the two fragments using the primer pair khb102/khb128. In the same way as described above, flanking regions were added to the fusion fragment. Then, the final PCR product was used to transform SPH154, giving rise to strain SPH229.
Construction of the PBP2x hybrid protein containing the transmembrane domain from PBP2b (strain SPH231) was done by amplifying a DNA fragment consisting of codons 12-34 from pbp2b using primers khb268 and khb269 and DNA from strain RH1 as template. The 59-end of this fragment was first fused to a fragment consisting of the region upstream of pbp2x (~1000 bp) plus codons 1-29 from pbp2x. Primers khb31 and khb271 were used to amplify the upstream fragment, whereas primers khb31 and khb269 were subsequently used to fuse the 39-end of this fragment to the 59-end of the small fragment encoding the PBP2b transmembrane segment. Next, a fragment consisting of pbp2x (starting from codon 52) and~1000 bp of the 39 flanking region was amplified with primers khb266 and khb34. Finally, primers khb31 and khb34 were used to fuse the resulting fragment to the 39-end of the previous construct. The 59 and 39 flanking fragments were both amplified using genomic DNA from strain SPH165 as template. The final fragment was used to transform SPH154, giving rise to strain SPH231.
Strain SPH232, which produces a PBP2b hybrid protein containing the transmembrane domain from PBP2x, was constructed as described in the paragraph above. The region corresponding to codons 29-51 of pbp2x was amplified with the primer pair khb264/ khb265 using DNA from strain RH1 as template. Using DNA from strain SPH158, a fragment consisting of the 59 flanking region of pbp2b and codons 1-12 of pbp2b was amplified with primers khb31 and khb267, and fused to the 59-end of the small fragment encoding the transmembrane domain of PBP2x by amplification with primers khb31 and khb265. Next, using the same template DNA, a fragment consisting of pbp2b (starting from codon 35) and~1000 bp of the 39 flanking region was amplified with primers khb266 and khb34. The resulting fragment was fused to the 39-end of the previous fragment by amplification with primers khb31 and khb34. The final PCR product was used to transform SPH154, giving rise to strain SPH232.
In strain SPH238, the transmembrane domain of PBP2x from S. pneumoniae R6 was replaced by the transmembrane domain of PBP2x from Streptococcus mitis B6. To make the chimeric pbp2x gene, a DNA fragment corresponding to codons 28-50 of pbp2x from S. mitis B6 was amplified with the khb321/khb322 primer pair. A fragment corresponding to~1000 bp of the 59 flanking region plus codons 1-27 of pneumococcal pbp2x at the 39-end was then amplified from SPH165 template DNA using primers khb323 and khb31. The two fragments were fused by PCR using primers khb31 and khb322. Then, using the same template DNA, a fragment consisting of pbp2x (starting from codon 51) and~1000 bp of the 39 flanking region was amplified with primers khb324 and khb43. The resulting fragment was fused with the previous fragment by overlap extension PCR using primers khb31 and khb34. The final fragment was used to transform SPH154, giving rise to strain SPH238.
In strains ectopically expressing the mutant or hybrid PBP constructs described above, attempts were made to replace the native pbp2x or pbp2b gene by a Janus cassette. The Dpbp2x : : Janus and Dpbp2b : : Janus fragments used were constructed as described by Berg et al. (2013) . If no viable transformants were obtained, even after repeated attempts, we concluded that the strain was not able to survive with the mutant/ hybrid PBP protein.
To make FLAG-tagged versions of PBP2x, the 3xFLAG-tag was added to the C terminus of wild-type PBP2x, the PBP2x chimera containing the cytoplasmic tail and transmembrane domain of PBP2b, the PBP2x (R22D) mutant and the PBP2x (F37A, F40A, F44A) mutant. Genomic DNA from strains SPH165, SPH226, SPH211 and SPH257, respectively, served as template to amplify the various PCR fragments needed to generate the above constructs. The FLAG-tag was incorporated into the forward khb308 and reverse khb309 primers. In all strains used as template for PCR the pbp2x gene was located at the ectopic site behind the P comX promoter. As a first step to make the FLAG-tagged constructs, a DNA fragment consisting of the 59 flanking region and pbp2x with a C-terminal FLAG-overhang was amplified using primers khb31 and khb309. Then, a fragment consisting of the FLAG-tag and the 39 flanking region was amplified using primers khb308 and khb34. The two fragments were fused using primers khb31 and khb34. The resulting fragments from the four templates were introduced into SPH154 by natural transformation. This gave rise to strains SPH234, SPH235, SPH236 and SPH244, which upon addition of ComS* produced FLAG-tagged wild-type PBP2x, the PBP2x/PBP2b chimera, PBP2x (R22D) and PBP2x (F37A, F40A, F44A), respectively. Replacement of the native pbp2x gene in strain SPH234 by a Janus cassette, as described by Berg et al. (2013) , gave rise to strain SPH237.
PBP2b depletion. Strain SPH158 was grown in C medium supplied with 0.2 mM ComS*. When the culture reached an OD 492 of~0.3, the bacteria were harvested by centrifugation. To remove ComS* from the growth medium the cells were washed once in C medium. The washed cells were resuspended in C medium with (0.2 mM) or without ComS* to an OD 492 of~0.05. Next, a twofold dilution series of the cells was made in a 96-well NBS clear bottom microtitre plate (Corning). The plate was incubated at 37 uC and OD 492 was measured automatically at 10 min intervals in a Fluostar Optima luminometer (BMG labtech). Bacteria used for scanning electron microscopy (SEM) were grown for about 8 h in the absence of ComS* inducer before they were harvested and prepared for SEM (for details, see Berg et al., 2013) .
Scanning electron microscopy. Bacterial cultures of strains SPH233 and SPH158 were grown in the presence of 0.2 mM ComS* to an OD 550 of~0.3. In addition, SPH158 cells were subjected to PBP2b depletion as described above. Volumes of 1.5 ml of each culture was fixed using 600 ml of 7.5 % (w/v) paraformaldehyde and 0.018 % (v/v) glutardialdehyde in PBS at pH 7.4. After overnight fixation at 4 uC the cells were prepared for SEM as described by Berg et al. (2013) .
Labelling of PBPs with Bocillin FL. PBPs of exponentially growing pneumococci (OD 550 of 0.25) were labelled with the fluorescent penicillin Bocillin FL (Molecular Probes) as described by Rutschmann et al. (2007) . Labelled PBPs were separated by SDS-PAGE at 3 V cm 22 for 135 min using a 10 % separation gel. After electrophoresis the fluorescently labelled PBPs were visualized in a Typhoon 8600 Variable Mode Imager 251 (Molecular Dynamics, Amersham Pharmacia Biotech).
Fluorescence microscopy of FLAG-tagged proteins.
Fluorescence microscopy of 3xFLAG-tagged proteins was performed as described by Wayne et al. (2010) . Briefly, 5 ml of the cell cultures was harvested at an OD 550 of~0.25, fixed in 4 % paraformaldehyde and stored in GTE (50 mM glucose, 1 mM EDTA, 20 mM Tris/HCl, pH 7.5) at 4 uC overnight. The following day 50 ml of the cell suspension was added to each microscope slide. The slides were left on the bench for 5 min for cells to attach. After removing unattached cells by aspiration, slides were carefully washed by submersion in PBS. Next, the slides were treated with PBST (0.2 % Triton X-100 in PBS) and then immersed in 220 uC MeOH for 10 min. After air drying, the slides were blocked for 1 h in PBST containing 5 % skimmed milk powder (PBST-M). Subsequent to the blocking step, the slides were treated with anti-FLAG antibody (Sigma, 1 : 200 in PBS-M) for 1 h followed by treatment with a mix of DAPI (0.2 mg ml 21 ) and anti-rabbit Alexa 488 (Molecular Probes, 1 : 100 in PBS-M) for 1 h. Between every step the microscope slides were washed with PBS. After the final washing step, slides were air-dried and 7 ml Slowfade Gold antifade reagent (Invitrogen) was added before coverslips were applied. The samples were imaged using a Zeiss LSM 700 confocal microscope.
RESULTS

Swapping of cytoplasmic tails and transmembrane domains between PBP2x and PBP2b
To investigate whether the cytoplasmic tails and transmembrane regions of PBP2x and PBP2b serve important biological functions in addition to anchoring these transpeptidases to the cytoplasmic membrane, we constructed a number of PBP2x/PBP2b chimeras and tested whether pneumococci harbouring the resulting hybrid proteins were viable. As both PBP2x and PBP2b are essential the various chimeric proteins were expressed ectopically by placing their respective genes behind the inducible P comX promoter. This promoter is part of a titratable gene expression/depletion system (ComRS) recently developed for studies of essential proteins in S. pneumoniae (Berg et al., 2011 . The ComRS system originates from Streptococcus thermophilus where it regulates competence development through a quorum-sensing-like mechanism (Fontaine et al., 2010) . Pneumococcal strains harbouring this system have the P comX promoter and the transcriptional activator ComR inserted at neutral sites in their genomes. Transcription of genes inserted behind P comX is induced by addition of the synthetic 8 aa peptide ComS* to the culture medium. ComS* is internalized by the endogenous Ami oligopeptide transporter and stimulates transcription by activating ComR through direct physical interaction. The level of target gene transcription increases with increasing concentration of ComS*. Maximum rate is reached at an external concentration of approximately 2 mM ComS*. As there are no close homologues of the ComR and ComS proteins encoded in the genome of S. pneumoniae, the ComRS system does not interfere with the normal metabolism of this bacterium.
After inserting the gene encoding a chimeric PBP2x or PBP2b protein downstream of P comX , we tried to delete the corresponding wild-type gene by replacing it with the counterselectable Janus cassette (Sung et al., 2001) . The Janus cassette (kan-rpsL + ) consists of a kanamycin resistance gene, and a gene conferring sensitivity to streptomycin. Attempts to delete the wild-type pbp2x or pbp2b gene were performed by transforming the appropriate strain (see Methods) with a PCR fragment consisting of the Janus cassette flanked by~1000 bp sequences corresponding to the upstream and downstream regions of the target pbp gene. Transformants were selected for by plating on TH agar containing kanamycin (400 mg ml -1 ) and 0.2 mM ComS* for ectopic expression of the chimera in question. If no transformants were obtained, even after the experiment had been repeated at least three times, the chimeric protein was considered to be unable to replace the wild-type protein. In some cases, a small number of false positives were obtained. Subsequent characterization of these transformants revealed that the wild-type gene was still intact, demonstrating that the ectopically expressed chimera could not functionally substitute for the native transpeptidase. The results presented in Fig. 1 show that all PBP2x chimeras in which the cytoplasmic tail and/or the transmembrane domain were replaced by the corresponding region(s) from PBP2b were non-functional. This indicates strongly that the cytoplasmic tail as well as the transmembrane segment of PBP2x constitute essential subdomains of this protein that in addition to membrane anchoring serve other important functions. In the opposite experiment, the cytoplasmic tail and/or the transmembrane domain of PBP2b were replaced with the equivalent regions of PBP2x. In strain SPH227, which ectopically expresses a PBP2b chimera containing both the cytoplasmic tail and the transmembrane domain of PBP2x, it was not possible to delete the wild-type pbp2b gene. In contrast, viable transformants were obtained when the native pbp2b gene was deleted in strains expressing chimeras containing only the cytoplasmic tail (strain SPH230) or the transmembrane domain (strain SPH233) of PBP2x (Fig. 1) .
Effects of the chimeric PBP2b proteins on growth and morphology
To determine whether the altered PBP2b proteins produced by the SPH230 and SPH233 strains affected their ability to grow and proliferate, their growth rates were compared with that of strain SPH158. SPH158 has a wildtype pbp2b gene inserted behind the P comX promoter, but lacks the native version of this gene. All strains were grown in the presence of 0.2 mM ComS* inducer. Interestingly, replacement of the~12 aa cytoplasmic tail of PBP2b with the corresponding~27 aa cytoplasmic domain of PBP2x had almost no effect on the growth rate of the SPH230 mutant (Fig. 2) . Strain SPH233, by contrast, displayed clear growth defects. It grew slower during the exponential phase, and started to lyse immediately after reaching the stationary phase (Fig. 2) . Examination of the strains by light microscopy showed that strain SPH233 had a highly altered morphology, whereas strain SPH230 appeared normal. Closer examination of strain SPH233 by SEM revealed that, in contrast to the strain expressing wild-type PBP2b, it forms long chains of cells that are compressed in the direction of the long axis (Fig. 3a, b) . In a recent paper, we reported that pneumococci strongly depleted in PBP2b display the same morphology (Fig. 3c) . The rapid autolysis observed in SPH233 cultures entering the stationary phase was also observed with PBP2b-depleted cultures . This demonstrates 
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that, although the SPH233 strain survives with the PBP2b chimera, it is a poor substitute for the wild-type protein.
Identification of conserved and functionally important amino acids in the cytoplasmic and transmembrane domains of PBP2x
The fact that PBP2x chimeras containing a cytoplasmic tail or transmembrane domain from PBP2b could not substitute for the wild-type protein indicates that both of these domains are essential for the proper functioning of PBP2x. An amino acid sequence alignment of this region of PBP2x, with sequences derived from 19 streptococcal species plus Enterococcus faecium, showed that there are several conserved amino acid positions in each domain.
In the cytoplasmic tail the RxxPxxNRxxVG conserved sequence motif was identified, while three phenylalanine residues were found to be absolutely conserved in the transmembrane domain (Fig. 4) . We used site-specific mutagenesis to further investigate the biological significance of these motifs. First, we constructed a set of mutants in which each of the conserved positions in the cytoplasmic tail-motif was substituted by alanine. All strains producing these mutated PBP2x proteins were viable, suggesting that substitution with alanine at a single position might not be sufficient to disrupt the function of the cytoplasmic domain (Table 3) . We therefore substituted both asparagine and arginine at positions 21 and 22 (S. pneumoniae R6 numbering) by alanine. These two amino acids, together with valine at position 25, constitute the most highly conserved amino acid positions in the cytoplasmic part of streptococcal PBP2x. They are even conserved in Enterococcus faecium (Fig. 4) . In the resulting mutant strain (SPH210), the native pbp2x gene could not be deleted, demonstrating that the N21A/R22A double mutation is lethal. As the conserved arginine at position 22 is positively charged we wondered whether a negatively charged amino acid in this position would be less tolerated than an alanine. This turned out to be the case, as it was not possible to knock out the native pbp2x gene in a strain (SPH211) producing a PBP2x protein carrying a single R22D substitution. Another interesting finding was that while an R22A mutation in PBP2x is tolerated (strain SPH215), an R22A/R23A double mutation is lethal (Table 3) .
To determine whether the three conserved phenylalanines in the transmembrane segment of PBP2x (see Fig. 4 ) are functionally important, they were replaced by alanines. Two different mutants were constructed. In one of them (SPH240), F37 and F40 were substituted by alanines, while F37, F40 and F44 were replaced by alanines in the other (SPH257). Following the same procedure as described above, we first inserted the mutated pbp2x genes behind the P comX promoter for ectopic expression. Next, we attempted to delete the native pbp2x gene in each of the resulting mutant strains by insertion of a Janus cassette. We obtained transformants that were able to survive with the PBP2x mutant protein containing the F37A/F40A substitutions (SPH241). Also, in the F37A/F40A/F44A triple mutant viable transformants were recovered. Together, these results show that the three conserved phenylalanines in the transmembrane segment of PBP2x are not essential for survival of S. pneumoniae under laboratory conditions.
Assessment of the penicillin-binding properties of lethal mutants of PBP2x and PBP2b
Both PBP2x and PBP2b are extracellular proteins that are anchored to the cytoplasmic membrane by a single transmembrane-spanning segment near the N terminus. For this reason, it is likely that reciprocal exchanges of the cytoplasmic and transmembrane domains of PBP2x and PBP2b will give rise to chimeras with the same bitopic membrane orientation as the wild-type proteins. To determine whether the extracellular domains of the lethal PBP2x and PBP2b mutant proteins constructed in the present study fold into the correct 3D structure, we investigated if they are able to bind a fluorescent derivative of penicillin V (Bocillin FL). To visualize Bocillin FL-labelled PBPs they were separated by SDS-PAGE and scanned with a FluorImager (Zhao et al., 1999 ). As it is not possible to isolate and grow strains expressing a lethal PBP2x or 
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PBP2b mutant protein, we tested strains that express both the lethal PBP and the corresponding wild-type PBP. In these strains transcription of the wild-type gene was under control of the native promoter, while transcription of the chimeric/mutant PBP gene was under control of the P comX promoter. To discriminate between the wild-type and the corresponding chimeric/mutant PBP we overexpressed the latter by adding 0.2 mM ComS* to the growth medium. Consequently, if the chimeric/mutant PBP binds Bocillin FL it will emerge as a prominent band in the SDS-PAGE gel that overshadows the wild-type protein.
Our results showed that all lethal PBPs, i.e. those hybrid or mutant constructs that were unable to substitute for the corresponding wild-type PBPs, bind Bocillin FL (Fig. 5) . This shows that all of them have correctly folded and functional transpeptidase domains.
Cell surface localization of PBP2x mutant proteins by immunofluorescence microscopy. The PBP2x chimera carrying the cytoplasmic and transmembrane domains of PBP2b was unable to substitute for wild-type PBP2x. This could be due to mislocalization of the protein. It has been reported previously that the membrane anchor of PBP3 (FtsI), which is the Escherichia coli homologue of PBP2x, functions as a cell surface localization signal (Weiss et al., 1999; Wissel et al., 2005) . We therefore wondered whether exchanging the native transmembrane segment and cytoplasmic tail of PBP2x with the corresponding regions from PBP2b would interfere with the localization of the resulting hybrid protein. To detect the hybrid protein in living pneumococci we added a triple FLAG-tag to its C-terminal end. Cells (SPH235) expressing this protein ectopically from the P comX promoter were fixed with 4 % (w/v) paraformaldehyde and visualized by immunofluorescence microscopy using anti-FLAG primary antibody and a fluorescent secondary antibody. To survive with the nonfunctional hybrid protein, the native pbp2x gene of cells of strain SPH235 was left intact. As a positive control we used a strain (SPH234) that has an intact pbp2x gene and expresses a wild-type FLAG-tagged PBP2x protein from the P comX promoter. Transcription from the P comX promoter was induced by growing the cells in the presence of 0.2 mM ComS*. The results showed that both the wild-type and the hybrid PBP2x proteins localize to the septum (Fig. 6a, b) . Interestingly, the native pbp2x gene of the SPH234 control strain could be deleted without any noticeable deleterious effect. This demonstrates that addition of a 3xFLAG tag to The purpose of the experiment was to show that the lethal PBP2x and PBP2b mutant proteins investigated bind penicillin, i.e. have a correctly folded 3D structure. As the lethal PBP constructs are not able to support growth on their own they were expressed ectopically from the P comX promoter while the corresponding native gene was left intact. To discriminate between the native and mutant PBPs the mutant version was overexpressed by addition of 0.2 mM ComS* to the growth medium. Consequently, if the mutant PBP is correctly folded and able to bind Bocillin FL it will emerge as a strong band that will overshadow the band corresponding to wild-type PBP. The following gene constructs were placed under control of the P comX promoter for ectopic expression: strain RH1, none; strain SPH162, wild-type pbp2x gene; strain SPH231, pbp2x chimera encoding the transmembrane domain of PBP2b; strain SPH228, pbp2x chimera encoding the cytoplasmic domain of PBP2b; strain SPH226, pbp2x chimera encoding the transmembrane and the cytoplasmic domains of PBP2b; strain SPH211, pbp2x gene containing the R22D mutation; strain SPH210, pbp2x gene containing the N21A and R22A mutations; strain SPH177, wild-type pbp2b gene; SPH227, pbp2b chimera encoding the transmembrane and the cytoplasmic domains of PBP2x.
the C-terminal end of PBP2x does not significantly impede the function of the protein.
In addition to the PBP2x hybrid protein, we also investigated the localization of the PBP2x proteins carrying the R22D single or the F37A/F40A/F44A triple mutation (see Table 3 ). To determine whether these substitutions affected the localization of the resulting PBP2x mutant protein, we constructed strains (SPH236 and SPH244) expressing PBP2x (R22D) and PBP2x (F37A/F40A/F44A) mutant proteins with triple FLAG-tags added to their Cterminal ends. The native pbp2x genes of the two strains were left intact. To determine the localization of the PBP2x (R22D) and PBP2x (F37A/F40A/F44A) mutant proteins we followed the same procedure as described above. The results showed that both mutant proteins localize to the septal ring (Fig. 6c, d ).
DISCUSSION
Our results clearly demonstrate that the transmembrane and cytoplasmic domains of PBP2x from S. pneumoniae have functions that extend beyond that of a simple anchoring device. The finding that all non-functional chimeras of PBP2x bind Bocillin FL shows that they are processed normally and adopt the correct 3D structure. Hence, the observed lethal phenotype of these chimeric PBP2x proteins is not due to low expression or misfolding.
The most plausible interpretation of our results is that the transmembrane and cytoplasmic domains of PBP2x are important because they are involved in intermolecular interactions. To further explore this hypothesis we compared the N-terminal amino acid sequences of several different PBP2x proteins to look for conserved positions (Fig. 4) . A motif with the consensus RxxPxxNRxxVG was highly conserved in the cytoplasmic tail, while a triplephenylalanine motif (FxxFxxxF) was conserved in the transmembrane a-helical anchor of PBP2x. We noted that the spacing of the three phenylalanines implies that they are located on the same side of the helix. This made us suspect that this face of the a-helix might be involved in protein-protein interactions.
Mutational analysis of the conserved RxxPxxNRxxVG motif confirmed that the cytoplasmic tail of PBP2x constitutes an indispensable part of the protein by showing that an N21A/R22A double or an R22D single substitution is not tolerated. It was possible to substitute R22 by an alanine, but no viable transformants were obtained for the R22A/R23A double mutant. This suggests that the positive charge of R22 is important and that the R22A mutant was viable because the positive charge of R23 could substitute for the loss of R22.
As shown in the Results, it is not possible to exchange the transmembrane segment of PBP2x with the corresponding segment of PBP2b. It was therefore unexpected that replacement of wild-type PBP2x with the PBP2x (F37A/ F40A/F44A) mutant protein was tolerated. Perhaps it is not the loss of the native PBP2x segment per se that is lethal, but rather the introduction of the transmembrane segment of PBP2b. A more likely explanation, in our view, is that the hypothetical interaction between the PBP2x transmembrane segment and one or more partner proteins is not fully disrupted by the F37A/F40A/F44A substitutions. It is possible that the postulated partner interacts with both the transmembrane segment and the cytoplasmic tail. A large contact surface area that encompasses both domains might explain why the F37A/F40A/F44A substitutions and some of the substitutions in the conserved RxxPxxNRxxVG motif were tolerated. Further work is needed to clarify this issue.
Studies performed in Escherichia coli have shown that PBP1B forms a homodimer (Bertsche et al., 2005; Zijderveld et al., 1991) . Whether pneumococcal PBPs form dimers has not been firmly established. However, using a two-hybrid assay with Escherichia coli as host, Maggi et al. (2008) obtained evidence that PBP2x from S. pneumoniae selfinteracts in vivo. A possible role of the PBP2x transmembrane a-helix is therefore to mediate self-dimerization. (Morlot et al., 2013) . Taking our data and the data described above into consideration we think that it is likely that DivIB associates with the transmembrane and/or cytoplasmic domain of PBP2x. This working hypothesis will, of course, have to be substantiated by further studies. Although the large extracellular loop of FtsW is believed to be important for the observed interaction between this protein and PBP2x, additional contact between these proteins cannot be ruled out. In fact, it is possible that PBP2x interacts with both DivIB and FtsW through its transmembrane domain and/or cytoplasmic domain.
Previous studies in other species indicate that the localization signal of class B PBPs resides in the transmembrane segment. A domain swap study in Bacillus subtilis, involving two class B transpeptidases (PBP2a and PBP2b) with different localization patterns, suggested that their cytoplasmic and/or transmembrane domains are the determinants for their cellular localization (Xue, 2008) . Similarly, studies in Escherichia coli have shown that correct localization of PBP3, a class B transpeptidase needed for the cross-linking of septal peptidoglycan, depends on an intact membrane anchor (Weiss et al., 1999) . Weiss et al. (1999) exchanged the native membrane-spanning segment of a fusion protein consisting of GFP and PBP3 with the corresponding segment of the maltose transport protein MalF. This resulted in a complete loss of septal localization. It was later demonstrated that a 26 aa fragment, corresponding roughly to the transmembrane helix of PBP3, is sufficient to direct GFP to the septum of Escherichia coli cells (Wissel et al., 2005) . Our results show that a non-functional PBP2x hybrid protein in which the native cytoplasmic and transmembrane domains have been exchanged with the corresponding domains from PBP2b still localizes to the septum (Fig. 6b) . Unfortunately, the localization patterns of pneumococcal PBP2x and PBP2b are indiscernible when studied by immunofluorescence microscopy. Thus, even though the hybrid protein is detected in the mid-cell region, it is not possible to determine whether it localizes as PBP2x or PBP2b. However, the fact that the non-functional PBP2x (R22D) mutant protein localizes to the septum suggests that the cytoplamic domain of pneumococcal PBP2x does not function as a major localization signal. Recently, data providing strong evidence that septal localization of PBP2x in S. pneumoniae depends on its PASTA domains were reported by Peters et al. (2014) . Their data are in good agreement with those obtained in this study. Nevertheless, it cannot be ruled out that the membrane anchor and/or cytoplasmic tail play a minor role as one of several regions that contribute to the correct positioning of PBP2x at the division site.
The PBP2b transpeptidase of S. pneumoniae does not contain PASTA domains. Hence, another part of the protein must direct PBP2b to its proper position at the cell surface. Our data show that strain SPH230, which expresses a PBP2b chimera containing the cytoplasmic domain of PBP2x, is viable. Thus, the cytoplasmic domain can probably be ruled out as a major localization signal of PBP2b. Strain SPH233, by contrast, which expresses a PBP2b chimera containing only the transmembrane segment from PBP2x, struggled to grow and displayed a phenotype identical to that of strongly PBP2b-depleted cells (Fig. 3) . Interestingly, strain SPH226, which produces a PBP2b hybrid containing both the cytoplasmic and the transmembrane domain of PBP2x, was not viable. An alignment of the amino acid sequences of the cytoplasmic and transmenbrane domains of PBP2b from different members of the genus Streptococcus plus Enterococcus faecium revealed six fully conserved amino acid positions in the transmembrane domain, but none in the cytoplasmic domain (alignment not shown). However, a conserved arginine was found to be located at the interface between the cytoplasmic and transmembrane domains. The absence of conserved amino acid positions in the cytoplasmic domain of PBP2b is in accordance with our finding that this part of PBP2b does not play a vital role in pneumococcal growth and survival. The transmembrane segment, by contrast, is important, as its replacement in strain SPH233 with the corresponding segment of PBP2x gave rise to cells with severe defects in growth and morphology (Figs 2 and  3) . The fact that strain SPH233 and a strain severely depleted in PBP2b display the same drastic morphological alterations (Fig. 3) indicates strongly that the transmembrane segment of PBP2b is required for correct assembly of the peripheral peptidoglycan synthesis machinery. A possible interpretation of these results is that the transmembrane segment constitutes an important localization signal, while the cytoplasmic tail contributes to a lesser degree. For reasons unknown, detection of FLAG-tagged wild-type PBP2b by immunoflorescence microscopy, as described for PBP2x, did not work well in our hands. The fluorescence signal obtained was too weak to be recorded with a satisfactory signal-tonoise ratio. We were therefore not able to use this method to study the localization of the PBP2b hybrid proteins, and consequently were unable to verify or refute the assumption that the transmembrane segment of PBP2b is an important localization signal.
In summary, our results show that the cytoplasmic domain of PBP2x and the transmembrane domains of PBP2x and PBP2b are essential for the proper functioning of these PBPs. Because of their important functions, these domains and their interaction partners represent attractive targets for the development of new antimicrobial compounds.
